Skip to main content
Erschienen in: Medical Oncology 11/2016

01.11.2016 | Letter to the Editor

Correspondence on the article: “Patients treated with neoadjuvant chemotherapy + radical surgery + adjuvant chemotherapy in locally advanced cervical cancer: long-term outcomes, survival and prognostic factors in a single-center 10-year follow-up”

verfasst von: Nasir Ali, Ahmed Nadeem Abbasi, Muhammad Atif Mansha

Erschienen in: Medical Oncology | Ausgabe 11/2016

Einloggen, um Zugang zu erhalten

Excerpt

Our team has gone through this article authored by Luvero et al. [1]. Certainly, 10-year follow-up of 90 cervical cancer patients is an impressive long-term follow-up. In this study, authors reported a negative correlation for involved nodes and outcome and also mentioned that site of involved nodes is not related to survival. Our team is inclined to disagree with this statement. In one study by Kidd et al. [2], it was reported that on PET/CT imaging the more distant level of nodal involvement was associated with poor survival. In another study by Paumier et al. [3], three-year survival was 58 and 24 % in patients without and with paraaortic lymph node involvement, respectively. These patients were staged by PET/CT. …
Literatur
1.
Zurück zum Zitat Luvero D, Plotti F, Aloisi A, Capriglione S, Ricciardi R, Miranda A, et al. Patients treated with neoadjuvant chemotherapy + radical surgery + adjuvant chemotherapy in locally advanced cervical cancer: long-term outcomes, survival and prognostic factors in a single-center 10-year follow-up. Med Oncol. 2016;33(10):110.CrossRefPubMed Luvero D, Plotti F, Aloisi A, Capriglione S, Ricciardi R, Miranda A, et al. Patients treated with neoadjuvant chemotherapy + radical surgery + adjuvant chemotherapy in locally advanced cervical cancer: long-term outcomes, survival and prognostic factors in a single-center 10-year follow-up. Med Oncol. 2016;33(10):110.CrossRefPubMed
2.
Zurück zum Zitat Kidd EA, Siegel BA, Dehdashti F, Rader JS, Mutch DG, Powell MA, et al. Lymph node staging by positron emission tomography in cervical cancer: relationship to prognosis. J Clin Oncol. 2010;28(12):2108–13.CrossRefPubMed Kidd EA, Siegel BA, Dehdashti F, Rader JS, Mutch DG, Powell MA, et al. Lymph node staging by positron emission tomography in cervical cancer: relationship to prognosis. J Clin Oncol. 2010;28(12):2108–13.CrossRefPubMed
3.
Zurück zum Zitat Paumier A, Blanchard P, Mazeron R, Dumas I, Morice P, Lhomme C, et al. Outcome of cervical carcinoma with locoregional lymph node involvement by FDG-PET. Cancer Radiother. 2012;16(3):183–9.CrossRefPubMed Paumier A, Blanchard P, Mazeron R, Dumas I, Morice P, Lhomme C, et al. Outcome of cervical carcinoma with locoregional lymph node involvement by FDG-PET. Cancer Radiother. 2012;16(3):183–9.CrossRefPubMed
4.
Zurück zum Zitat Duenas-Gonzalez A, Zarba JJ, Patel F, Alcedo JC, Beslija S, Casanova L, et al. Phase III, open-label, randomized study comparing concurrent gemcitabine plus cisplatin and radiation followed by adjuvant gemcitabine and cisplatin versus concurrent cisplatin and radiation in patients with stage IIB to IVA carcinoma of the cervix. J Clin Oncol. 2011;29(13):1678–85.CrossRefPubMed Duenas-Gonzalez A, Zarba JJ, Patel F, Alcedo JC, Beslija S, Casanova L, et al. Phase III, open-label, randomized study comparing concurrent gemcitabine plus cisplatin and radiation followed by adjuvant gemcitabine and cisplatin versus concurrent cisplatin and radiation in patients with stage IIB to IVA carcinoma of the cervix. J Clin Oncol. 2011;29(13):1678–85.CrossRefPubMed
Metadaten
Titel
Correspondence on the article: “Patients treated with neoadjuvant chemotherapy + radical surgery + adjuvant chemotherapy in locally advanced cervical cancer: long-term outcomes, survival and prognostic factors in a single-center 10-year follow-up”
verfasst von
Nasir Ali
Ahmed Nadeem Abbasi
Muhammad Atif Mansha
Publikationsdatum
01.11.2016
Verlag
Springer US
Erschienen in
Medical Oncology / Ausgabe 11/2016
Print ISSN: 1357-0560
Elektronische ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-016-0847-4

Weitere Artikel der Ausgabe 11/2016

Medical Oncology 11/2016 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.